home / stock / amrn / amrn news


AMRN News and Press, Amarin Corporation plc From 04/17/23

Stock Information

Company Name: Amarin Corporation plc
Stock Symbol: AMRN
Market: NASDAQ
Website: amarincorp.com

Menu

AMRN AMRN Quote AMRN Short AMRN News AMRN Articles AMRN Message Board
Get AMRN Alerts

News, Short Squeeze, Breakout and More Instantly...

AMRN - Amarin names Aaron Berg as interim president & CEO

2023-04-17 07:11:02 ET Amarin ( NASDAQ: AMRN ) announced on Monday the appointment of Aaron Berg as interim president and CEO, effective immediately. Berg, who has more than 25 years of biopharmaceutical industry experience, currently serves as Amarin's executive vice pres...

AMRN - Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O'Connor to Company's Board of Directors

DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Board of Directors has appointed Aaron Berg, currently Amarin’s Executive Vice President and President of the U.S. Business, as Interim P...

AMRN - Amarin: Sarissa Has Control, But Amarin Will Need Patience

2023-04-16 09:15:01 ET Summary Sarissa Capital has taken full control of Amarin. The previous management was doing some slow but decent work, but did not get time to show results. Sarissa hasn't disclosed material plans. In February, I wrote that while Amarin ( ...

AMRN - Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today

2023-04-04 15:53:30 ET U.S. stock markets are under heavy pressure today after two reports on job openings and factory orders came in weaker than expected. The key issue at play is a growing concern that the Federal Reserve's rate hiking campaign may spark a deep and long-lasting economic d...

AMRN - Amarin spikes as Israel clears heart disease therapy

2023-04-04 08:35:01 ET Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) added ~5% pre-market Tuesday after announcing that Israel’s Ministry of Health approved its fish oil-derived heart disease therapy Vazkepa (icosapent ethyl). Accordingly, Vazkepa will b...

AMRN - Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel's Ministry of Health

-- Approval of VAZKEPA® to Reduce the Risk of Cardiovascular (CV) Events in Adult Statin-Treated Patients at High CV Risk with Elevated Triglycerides and Other High-Risk Characteristics as Studied in REDUCE-IT –- -- Heart Disease Second Leading Cause of Death in Men and Wome...

AMRN - Amarin announces resignation of CEO

2023-03-31 09:18:55 ET Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) announced Friday that President and Chief Executive Officer Karim Mikhail has decided to step down, effective immediately. Amarin ( AMRN ), the developer of fish oil-derived therapy Vascep...

AMRN - Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl)

New Amarin Board Believes the Company Will Thrive with Proper Stewardship New Amarin Directors are Working with Urgency to Address Issues at Amarin DUBLIN, Ireland and BRIDGEWATER, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today released the fo...

AMRN - Amarin Corporation plc (AMRN) Cowen 43rd Annual Healthcare Conference (Transcript)

2023-03-08 18:12:02 ET Amarin Corporation plc (AMRN) Cowen 43rd Annual Healthcare Conference March 08, 2023, 01:30 PM ET Company Participants Karim Mikhail - President and CEO Conference Call Participants Georgi Yordanov - Cowen and Company Presentation...

AMRN - Amarin Corporation plc 2022 Q4 - Results - Earnings Call Presentation

2023-03-07 10:26:05 ET The following slide deck was published by Amarin Corporation plc in conjunction with their 2022 Q4 earnings call. For further details see: Amarin Corporation plc 2022 Q4 - Results - Earnings Call Presentation

Previous 10 Next 10